Skip to main content
. Author manuscript; available in PMC: 2007 Oct 31.
Published in final edited form as: Neurosci Lett. 2007 Jul 19;423(2):89–94. doi: 10.1016/j.neulet.2007.05.067

Fig. 4.

Fig. 4

CNTF- induced VIP mRNA in CE cells in stored donor human corneas demonstrated by real-time RT-qPCR. VIP mRNA level over that of the endogenous mRNA standard (cyclophilin B or β- actin) found in each of the two corneal halves (control vs CNTF-treated) of the same cornea was normalized against that of the control half and values derived from both the control and the CNTF-treated halves were given on Y-axis. CNTF treatment (0.1 nM, 24 h) increased VIP mRNA levels by (mean±SEM) 6.54±2.25 (N=7 corneas, p=0.024; cyclophilin B) and 2.32±0.59 (N=10 corneas, p=0.019; β-actin) folds.